Our studies highlight the significant impact of coexpressing Sf3b1-K700E and Mdr deletion in murine B cells and their role in CLL biology, with emphasis on how these 2 genetic lesions cooperate to alter B cell development, growth, and CLL progression. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.